Alison Moran

No ORCID on file · 1 paper in corpus
other 2013
BMC women's health ·doi:10.1186/1472-6874-13-8

BACKGROUND: NICE guidance on the investigation and treatment of ovarian cancer advocates that the tumour marker CA125 should be the first line investigation for women suspected of having ovarian cancer. METHODS: An internet-based survey, o…